SCHEMBL16623589

SCHEMBL16623589

N=C(Nc1ccccc1)c1c(N)cc[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.43
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.38
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
INCENP Q9NQS7 1/20 0.37
SLC22A12 Q96S37 2/20 0.36
PARP1 P09874 3/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.35
EPHX1 P07099 1/20 0.35
TSHR P16473 1/20 0.35
EPHX2 P34913 1/20 0.35
CDK9 P50750 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20311130 0.85 EGFR (0.44) EGFRKDM4EKMT2AMAPTPARP1
SCHEMBL12655661 0.84 EGFR (0.40) EGFRKDM4EGAAKMT2AAURKA
SCHEMBL12655657 0.84 HSD17B10 (0.43) EGFRKDM4EGAAKMT2AMAPT
SCHEMBL16623590 0.84 EGFR (0.37) EGFRAURKAAURKBINCENPPARP1
SCHEMBL20246564 0.82 PTGS1 (0.43) EGFRMAPTPARP1EPHX2
SCHEMBL20311022 0.82 EGFR (0.42) EGFRKDM4EKMT2AMAPTEPHX1
SCHEMBL20245973 0.81 EGFR (0.44) EGFRJAK2
SCHEMBL12655541 0.81 PTGS1 (0.48) GAAKMT2AMAPTTDP1TP53
SCHEMBL20246267 0.80 EGFR (0.43) EGFR
SCHEMBL20246252 0.80 MEN1 (0.48) EGFRKDM4EKMT2ATSHRJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976339-B1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2018-06-27 EP disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed